CellFE, a leader in non-viral gene editing technology, today announced a strategic collaboration with the Harbottle Lab at ...

Dr. Richard Harbottle, co-founder of TcellTech and researcher at DKFZ, added, "Using CellFE's technology to deliver our nanoSMAR vector platform enables the efficient genetic engineering of cells ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced three presentations that underscore ...

Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical therapeutic development.

Molecular biology has transitioned to a new era where precise genetic manipulation plays a critical role in research, medicine, and biotechnology. Among the vital tools in this field are cloning ...

Vector, a logistics workflow platform that enables shippers, carriers, and retailers to streamline operations, announced a strategic growth investment from BVP Forge to accelerate future growth. By ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

In 2017, the World Health Organization (WHO) endorsed the first ITN capable of improving protection against ...